Forgiving lens

Ophtec BV has received a CE mark for a new aspheric presbyopia correcting intraocular lens (IOL), Precizon Presbyopic, with a patent-pending continuous transitional focus (CTF) optical design.
“The new CTF optic seems to offer a safer surgical approach than traditional multifocal technologies available on the market, and addresses the fact that nature is not an optical bench and IOL seating is important for good performance,” said a company spokesman.
“The technology offers a full range of vision and, due to the CTF’s transitional zones, a smooth, continuous transition from near vision to infinity is achieved. Consequently, CTF ensures a more 'forgiving' lens that enables surgeons to treat a wider range of presbyopic patients with a higher degree of confidence,” he said.
Precizon Presbyopic will be commercially launched in October during the XXXV Congress of the ESCRS in Lisbon, Portugal. The product will initially be available in the European Union and a few selected markets.
www.ophtec.com
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.